Skip to main content
SpringerLink
Log in

Dexrazoxane: cardioprotective effects yet to translate into survival benefits

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jurga L, et al. Neoplasma 40: 259–262, 1993

    PubMed  CAS  Google Scholar 

  2. Speyer JL, et al. Can Treat Rev 17: 161–163, 1990

    Article  CAS  Google Scholar 

  3. Speyer JL, et al. J Clin Oncol 10: 117–127, 1992

    PubMed  CAS  Google Scholar 

  4. Von Hoff DD, et al. Ann Intern Med 91: 710–717, 1979

    Google Scholar 

  5. Inpharma 846: 26, 1992

  6. Weisberg SR, et al. Froc Am Soc Clin Oncol 11: 91, 1992

    Google Scholar 

  7. Maillard JA, et al. Proc Am Soc Clin Oncol 11: 91, 1992

    Google Scholar 

  8. Rosenfeld CS, et al. Proc Am Soc Clin Oncol 11: 62, 1992

    Google Scholar 

  9. Curran CF, et al. Can Treat Rev 18: 241–252, 1991

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dexrazoxane: cardioprotective effects yet to translate into survival benefits. Drugs Ther. Perspect 4, 7–8 (1994). https://doi.org/10.2165/00042310-199404050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199404050-00003

Keywords

Search

Navigation